Selexis Selected As Top Biotech
GENEVA, SWITZERLAND, December 19, 2007
Selexis SA, a Swiss-based biotechnology company offering technologies and services to enable significantly improved drug discovery, development, and cGMP production of biologics, announced today that it has selected by Geneva based FONGIT, a high-tech business support and evaluation organization, to receive the top award for achieving rapid growth and achievement in 2007.
“We are very proud to have been selected by the leadership at FONGIT to receive this top award for high-tech growth companies in the Geneva area”, said Dr. Igor Fisch, CEO of Selexis SA. “Our rapid growth is a testimony to the power of our unique technology and the dedication and effort by our highly skilled team of professionals and scientists – we are always active in the expansion of our technology and service offering.” Dr. Fisch added “We are looking forward to having another great year in 2008”.
About Selexis:
Selexis is a privately held biotechnology company dedicated to the development of innovative technologies and expert services that enables significant improvements in the time, effort and costs required to develop and maintain high-performance mammalian cell lines used in the expression of pharmaceutically relevant proteins (i.e. targets, MABs, rProteins). The company's core intellectual property portfolio is based on the discovery and application of enabling genetic elements that control the dynamic organization of chromatin within all mammalian cells. Application of the Selexis Genetic Elements™ using the SURE Cell Line DevelopmentSM process has enabled the rapid development of high performance cell lines for a number of pharmaceutically important programs.
About FONGIT:
FONGIT is a high-tech business incubator and part of the of the governmental business incubator program of the State of Geneva. Although FONGIT operates as a non-profit oriented, private foundation, its purpose is to create wealth, employment and opportunity to local, regional and national economies. As a support organization its mission is to actively support and assist early-stage companies and to provide the necessary assistance entrepreneurs to increase their chances to grow their own ventures. FONGIT was founded by Jean-Pierre Etter and operates in its present form since 1997
Selexis Genetic Elements™ and SURE Cell Line Development SM are trademarks of Selexis SA.
MORE INFORMATION:
EUROPE
Igor Fisch, Ph.D.
41 (0)22 308 93 60
Igor.FischATselexis.com
UNITED STATES
Andrew F. Sandford
(617) 595-5769
andrew.sanfordATselexis.com